EUVIMEDEUVIMED entdecken
Crossref

Quantitation of Plasma Bedaquiline Concentrations in Indian MDR‐TB Patients Using Liquid Chromatography–Tandem Mass Spectrometry

Rohan V Lokhande iD, Prerna R Arora iD, Anton Joubert, Ganesh R Bhagure, Zarir F Udwadia, Amita Gupta, Camilla Rodrigues, Jeffrey A Tornheim, Lubbe Wiesner, Tester F Ashavaid iD, MDR‐TB MUKT and RePORT India Study Team, Indo‐South Africa Study Team

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Rohan V Lokhande und 11 weiteren Autor:innen. Beteiligte Einrichtung: Research Laboratories, P.D. Hinduja Hospital and Medical Research Centre, Mumbai, India. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Diarylquinolines, Tuberculosis, Multidrug-Resistant, Antitubercular Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: RePORT International Coordinating Center, NIH HHS, Department of Science and Technology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bedaquiline (BDQ) is a diarylquinoline used for the treatment of multidrug‐resistant tuberculosis (MDR‐TB) with a mechanism of action that inhibits the mycobacterial adenosine triphosphate synthase. There is a limited literature on the pharmacokinetics (PK) of BDQ in MDR‐TB patients globally and even less from India. We aimed to develop a rapid, selective, sensitive, and robust high‐throughput liquid chromatography–tandem mass spectrometry (LC–MS/MS) method to evaluate the PK of BDQ from the plasma of people with MDR‐TB. The analyte was extracted from plasma by protein precipitation. The separation was achieved on a reverse phase C18 column with a mixture of aqueous and organic mobile phase in gradient mode at a flow rate of 0.3 mL/min and detected on a triple quadrupole mass spectrometer. Linearity was obtained between 0.0313 to 4.0 mg/L, and the method was validated following bioanalytical method validation guidelines. BDQ concentrations were determined from plasma samples, and intensive PK testing was performed in samples from 23 patients. The median Cmax attained was 1.59 mg/L with a Tmax around 6 h for most of our patients. This method was successfully developed and validated for a pilot PK study in Indian MDR‐TB patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryDiarylquinolinesTuberculosis, Multidrug-ResistantAntitubercular AgentsHumansIndiaReproducibility of ResultsMaleLinear ModelsChromatography, LiquidAdultFemaleLimit of DetectionMiddle AgedSensitivity and Specificity

Stichwörter der Autor:innen

bedaquilineliquid chromatography–tandem mass spectrometrymultidrug‐resistant tuberculosispharmacokineticsplasma

Substanzen

bedaquilineDiarylquinolinesAntitubercular Agents

Autor:innen und Institutionen

  • Research Laboratories, P.D. Hinduja Hospital and Medical Research Centre, Mumbai, India.
  • Department of Chemistry, Satish Pradhan Dnyanasadhana College, Thane, India.
  • Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Center for Infectious Diseases in India, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Bloomberg School of Public Health, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Rohan V Lokhande, Prerna R Arora, Tester F Ashavaid

Förderung

  • RePORT International Coordinating Center
  • NIH HHS
  • Department of Science and Technology, Ministry of Science and Technology, India
  • NIAID NIH HHS
  • Department of Biotechnology, Ministry of Science and Technology, India
  • National Health and Education Society
  • National Institutes of Health

Zitieren

APA

Lokhande, R. V., Arora, P. R., Joubert, A., Bhagure, G. R., Udwadia, Z. F., Gupta, A., Rodrigues, C., Tornheim, J. A., Wiesner, L., Ashavaid, T. F., MDR‐TB MUKT and RePORT India Study Team, & Indo‐South Africa Study Team (2025). Quantitation of Plasma Bedaquiline Concentrations in Indian MDR‐TB Patients Using Liquid Chromatography–Tandem Mass Spectrometry. Biomedical Chromatography. https://doi.org/10.1002/bmc.70243

Vancouver

Lokhande RV, Arora PR, Joubert A, Bhagure GR, Udwadia ZF, Gupta A, et al. Quantitation of Plasma Bedaquiline Concentrations in Indian MDR‐TB Patients Using Liquid Chromatography–Tandem Mass Spectrometry. Biomedical Chromatography. 2025. doi:10.1002/bmc.70243

BibTeX
@article{Lokhande2025,
  author = {Lokhande, Rohan V and Arora, Prerna R and Joubert, Anton and Bhagure, Ganesh R and Udwadia, Zarir F and Gupta, Amita and Rodrigues, Camilla and Tornheim, Jeffrey A and Wiesner, Lubbe and Ashavaid, Tester F and MDR‐TB MUKT and RePORT India Study Team, MDR‐TB MUKT and RePORT India Study Team and Indo‐South Africa Study Team, Indo‐South Africa Study Team},
  title = {Quantitation of Plasma Bedaquiline Concentrations in Indian MDR‐TB Patients Using Liquid Chromatography–Tandem Mass Spectrometry},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70243}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche